After the mpox virus reemerged globally in 2022, people with HIV were identified as facing disproportionately higher risk and more severe consequences of infection. Doctors and public health specialists urged members of that population to pursue getting a smallpox vaccine thought to be effective against mpox, though little efficacy data existed for that use.
That changed this week. Research published in the journal Clinical Infectious Diseases indicates that vaccination against mpox is highly protective among people with HIV.
